HUMIRA

HUMIRA

Displaying 10 out of 8 results

  1. FILE PHOTO: Pharmaceutical tablets and capsules are arranged on a table in this picture illustratio

    More January US price hikes take 2020 tally to over 330 drugs with higher cost

    AbbVie Inc on Thursday raised the cost of rheumatoid arthritis treatment Humira, the world's top-selling medicine, joining other drugmakers that ...
  2. FILE PHOTO: A screen displays the share price for pharmaceutical maker AbbVie on the floor of the N

    AbbVie boosts 2019 profit outlook as Humira helps beat revenue estimates

    AbbVie Inc posted quarterly sales above estimates on Friday and raised the lower end of its 2019 profit forecast, helped by strong demand for ...
  3. FILE PHOTO: A screen displays the share price for drugmaker AbbVie on the floor of the New York Sto

    Humira, Rituxan top list of US drugs with biggest price increases - report

    AbbVie Inc's arthritis drug Humira and Roche Holding AG's cancer drug Rituxan top the list of seven treatments whose combined 2017 and 2018 price ...
  4. FILE PHOTO: A screen displays the share price for drugmaker AbbVie on the floor of the New York Sto

    Consumer groups, unions urge caution on US$63 billion AbbVie deal for Allergan

    About a dozen advocacy groups and unions, including Public Citizen and the American Federation of Teachers, wrote the Federal Trade Commission on ...
  5. The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey

    Merck's biosimilar to AbbVie's Humira wins FDA approval

    The U.S. Food and Drug Administration approved Merck & Co Inc's biosimilar to AbbVie Inc's blockbuster rheumatoid arthritis treatment Humira, the ...
  6. FILE PHOTO: The Allergan logo is seen in this photo illustration in Singapore

    AbbVie looks beyond Humira with US$63 billion deal for Botox-maker Allergan

    AbbVie Inc is nearing a deal to buy Botox-maker Allergan PLC for more than US$60 billion, the Wall Street Journal reported on Tuesday, citing ...
  7. FILE PHOTO:  A trader works by the post that trades AbbVie on the floor of the New York Stock Excha

    AbbVie's Skyrizi drug to treat psoriasis wins US approval

    AbbVie Inc said on Tuesday that the U.S. Food and Drug Administration approved its Skyrizi drug as a treatment for plaque psoriasis at a time when ...